Kuehn Law, PLLC is investigating Viking Therapeutics, Inc. (VKTX) for potential breaches of fiduciary duty. The probe focuses on allegations of self-dealing by certain company officers and directors.
The investigation follows a press release issued late on July 16, 2026. Kuehn Law is currently urging long-term VKTX stockholders to contact the firm regarding the matter.
Shareholders may be entitled to financial damages and corporate governance reforms if the investigation finds evidence of wrongdoing. Kuehn Law is conducting this inquiry as a shareholder litigation firm on behalf of Viking investors.